Sorry, I meant pink sheet stock, but, hey, medistem is look to be audited too, very cheap, very cheap stock and already have their IND approved, merger, buyouts from Roche, merger with Roche, buyout (just being sarcastic here...)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.